Insulet Operating Income Over Time
| GOV Stock | EUR 205.50 5.60 2.65% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Insulet Performance and Insulet Correlation. Insulet |
Cross Equities Operating Income Analysis
Compare Insulet and related stocks such as Cerence, TELES Informationstech, and BIOTIME Operating Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0S6 | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 38.9 M | 65.7 M | 38.3 M | (15.3 M) | 46.3 M | 13.1 M | 11.8 M | 11.2 M |
| TLIK | (597 K) | (597 K) | (597 K) | (597 K) | (597 K) | (597 K) | (597 K) | (329 K) | (2.1 M) | 4.8 M | (98.1 K) | (258.8 K) | (1.5 M) | (1.7 M) | (418.7 K) | (376.8 K) | (395.6 K) |
| BT3 | (59 M) | (59 M) | (59 M) | (59 M) | (59 M) | (59 M) | (59 M) | (40.7 M) | (41 M) | (38.9 M) | (26.4 M) | (49.2 M) | (22.5 M) | (24.7 M) | (21.5 M) | (24.7 M) | (25.9 M) |
| MS9 | 439.5 B | 439.5 B | 439.5 B | 439.5 B | 244.7 B | 69.4 B | (55.4 B) | 91.9 B | 29 B | 28.5 B | (9.6 B) | (48.4 B) | (183.3 B) | (214.7 B) | (70.8 B) | (63.7 B) | (60.5 B) |
| IB5A | (311.9 M) | (311.9 M) | (311.9 M) | (311.9 M) | (311.9 M) | (311.9 M) | (311.9 M) | (443.9 M) | (489.2 M) | (364.1 M) | (234.4 M) | (308.6 M) | (325.8 M) | (427.8 M) | (409.7 M) | (471.2 M) | (494.7 M) |
| MBJ | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (305.1 M) | (320.4 M) |
| MBJ | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (305.1 M) | (320.4 M) |
| TZO | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1 M) | (9.9 M) | (1.1 M) | (1.3 M) | (1 M) | (800.8 K) | (780.8 K) | (1.4 M) | (1.2 M) | (1.2 M) | (1.1 M) | (1.3 M) | (1.3 M) |
| AJW | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (3.3 B) | (3.1 B) | (3.3 B) | (5.6 B) | (15.6 B) | (16.3 B) | (12 B) | (9.1 B) | (8.2 B) | (8.6 B) |
| 9R5 | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (19.1 M) | (10.9 M) | (9.2 M) | (8.2 M) | (8.7 M) |
Insulet and related stocks such as Cerence, TELES Informationstech, and BIOTIME Operating Income description
Operating Income is the amount of profit realized from Insulet operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Insulet is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Insulet | GOV |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 100 Nagog Park, |
| Exchange | Frankfurt Exchange |
EUR 205.5
Check out Insulet Performance and Insulet Correlation. For more detail on how to invest in Insulet Stock please use our How to Invest in Insulet guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Insulet technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.